Loading organizations...
Loading organizations...
Biopharmaceutical company developing immune-targeted cancer treatments.
Corvus Pharmaceuticals has raised $75.0M across 1 funding round.
Corvus Pharmaceuticals has raised $75.0M in total across 1 funding round.
Corvus Pharmaceuticals has raised $75.0M in total across 1 funding round.
Corvus Pharmaceuticals's investors include Rock Springs Capital, Adams Street Partners, BlackRock, Cormorant Asset Management, Cowen Private Investments, Fidelity Management & Research Company, Jennison Associates, Novo Ventures, OrbiMed, Roche, Sphera Funds Management, T. Rowe Price Associates.
Corvus Pharmaceuticals has raised $75.0M across 1 funding round. Most recently, it raised $75.0M Series B in September 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 29, 2015 | $75.0M Series B | Rock Springs Capital | Adams Street Partners, BlackRock, Cormorant Asset Management, Cowen Private Investments, Fidelity Management & Research Company, Jennison Associates, Novo Ventures, OrbiMed, Roche, Sphera Funds Management, T. Rowe Price Associates |